The present review surveys the use of antiandrogen treatment to reduce sexual drive in men at risk for sexual offending. After briefly reviewing castration, the author traces the history of the use of medications to reduce sexual drive, focusing on the antiandrogens. Controversy surrounding their use and recent altematives are mentioned, with an emphasis on legal and ethical issues. One strong conclusion drawn is that antiandrogen medications should never be used as exclusive treatment for paraphilic and aggressive sexual behaviors.
Bartholomew, A.A. (1964). Some side effects of thioridazine. Medical Journal of Australia, 1, 57-59.
2.
Berlin, F.S. (1983). Sex offenders: A biomedical perspective and a status report on biomedical treatment. In J. G. Greer & I. R. Stuart (Eds.), The sexual aggressor. Current perspectives on treatment. New York: Van Nostrand Reinhold.
3.
Berlin, F.S. (1989). The paraphilias and depo-Provera: Some medical, ethical and legal considerations. Bulletin of the American Academy of Psychiatry and Law, 17, 233-239.
4.
Berlin, F.S., & Coyle, G.S. (1981). Sexual deviation syndromesThe Johns Hopkins Medical Journal, 149, 119-125.
5.
Berlin, F.S., & Meinecke, C.F. (1981). Treatment of sex offenders with antiandrogenic medication: Conceptualization, review of treatment modalities, and preliminary findings. American Journal of Psychiatry, 138, 601-646.
6.
Bradford, J.M.W. (1983). Hormonal treatment of sexual offenders. Bulletin of the American Academy of Psychiatry and the Law, 11, 159-169.
7.
Bradford, J.M.W. (1985). Organic treatments for the male sexual offender . Behavioral Sciences & the Law, 3, 355-375.
8.
Bradford, J.M.W. (1988). Organic treatment for the male sexual offender . In R. A. Prentky & V. L. Quinsey (Eds.), Human sexual aggression: Current perspectives (Vol. 258, pp. 193-202). New York: New York Academy of Sciences.
9.
Bradford, J.M.W. (1990). The antiandrogen and hormonal treatment of sex offenders. In W. L. Marshall, D. R. Laws, & H. E. Barbaree (Eds.), Handbook of sexual assault: Issues, theories, and treatment of the offender (pp. 297-310). New York: Plenum.
10.
Bremer, J. (1959). Asexualization: A follow-up study of 244 cases . New York: Macmillan.
11.
Cooper, A.J. (1981). A placebo-controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality. Comprehensive Psychiatry, 22, 458-465.
12.
Demsky, L.S. (1984). The use of depo-Provera in the treatment of sex offenders: The legal issues. Journal of Legal Medicine, 5, 295-322.
13.
Dickey, R. (1992). The management of a case of treatment-resistant paraphilia with a long-acting LHRH agonist. Canadian Journal of Psychiatry, 37, 567-569.
14.
Emmanuel, N.P., Lydiard, R.B., & Ballenger, J.C. (1991). Fluoxetine treatment of voyeurism [letter]. American Journal of Psychiatry, 248, 950.
15.
Fedoroff, J.P. (1993). Serotonergic drug treatment of deviant sexual interests. Annals of Sex Research, 6, 105-121.
16.
Field, L.H., & Williams, M. (1970). The hormonal treatment of sexual offenders. Medicine, Science and the Law, 10, 27.
17.
Gaensbauer, T.J. (1973). Castration in treatment of sex offenders: An appraisal . Rocky Mountain Medical Journal, 70, 23-28.
18.
Gaffney, G.R., and Berlin, F.S. (1984). Is there hypothalamic-pituitary-gonadal dysfunction in paedophilia? A pilot study. British Journal of Psychiatry , 145, 657-660.
19.
Gagne, P. (1981). Treatment of sex offenders with medroxyprogesterone acetate. American Journal of Psychiatry, 138, 644-646.
20.
Golla, F.L., & Hodge, R.S. (1949). Hormone treatment of sex offenders. Lancet, 1, 1006-1007.
21.
Gottesman, H.G., & Schubert, D.S.P. (1993). Low-dose oral medroxyprogesterone acetate in the management of the paraphilias. Journal of Clinical Psychiatry, 54, 182-188.
22.
Halleck, S.L. (1981). The ethics of antiandrogen therapy. American Journal of Psychiatry, 138, 642-643.
23.
Heim, N., & Hursch, C.J. (1979). Castration for sex offenders: Treatment or punishment? A review and critique of recentEuropean literature. Archives of Sexual Behavior, 8, 281-304.
24.
Heller, C.G., Laidlaw, W.M., Harvey, H.T., & Nelson, D.L. (1958). Effects of progestational compounds on the reproductive processes of the human male. Annals of the New York Academy of Sciences, 71, 649-665.
25.
Kafka, M.P. (1991). Successful antidepressant treatment of nonparaphilic sexual addictions and paraphilias in men. Journal of Clinical Psychiatry, 52, 60-65.
26.
Kafka, M.P. (1994). Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: An open trial. Annals of Clinical Psychiatry, 6, 189-195.
27.
Kafka, M.P. (1995a). Sexual impulsivity. In E. Hollander & D. J. Stein (Eds.), Impulsivity and aggression (pp. 201-222). Chichester : John Wiley & Sons.
28.
Kafka, M.P. (1995b). Current concepts in the drug treatment of paraphilias and paraphilia-related disorders. CNS Drugs, 3, 9-21.
29.
Kafka, M.P., & Prentky, R.A. (1992). Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men. Journal of Clinical Psychiatry, 534, 351-358.
30.
Kiersch, T.A. (1990). Treatment of sex offenders with depo-Provera. Bulletin of the American Academy of Psychiatry and the Law, 18, 179-187.
31.
Laschet, U., & Laschet, L. (1975). Antiandrogens in the treatment of sexual deviations of men. Journal of Steroid Biochemistry, 6, 821-826.
32.
Le Maire, L. (1956). Danish experiences regarding the castration of sexual offenders. Journal of Criminal Law, Criminology and Police Science, 47, 295-310.
33.
Lerner, L.J. (1964). Hormone antagonists: Inhibitors of specific activities of estrogen and androgen. Recent progress in hormone research (Vol. 20, pp. 454-490). New York: Academic Press.
34.
Lerner, L.G., Bianchi, A., & Barman, A. (1960). A-Norprogesterone: An androgen antagonist. Proceedings of the Society for Experimental Biology and Medicine, 103, 172-175.
35.
Litkey, L.J., & Feniczy, P. (1967). An approach to the control of homosexual practices . Intemational Journal of Neuropsychiatry, 3, 20-23.
36.
Maletzky, B.M. (1991). Treating the sexual offender. Newbury Park, CA: Sage.
37.
Melella, J.T., Travin, S., & Cullen, K. (1989). Legal and ethical issues in the use of antiandrogens in treating sex offenders. Bulletin of the American Academy of Psychiatry and the Law, 17, 223-231.
38.
Money, J. (1968). Discussion on hormonal inhibition of libido in male sex offenders. In R. P. Michael (Ed.), Endocrinology and human behavior. London : Oxford University Press.
39.
Money, J. (1970). Use of an androgen-depleting hormone in the treatment of male sex offenders. Journal of Sex Research, 6, 165-172.
40.
Money, J., & Bennett, R.G. (1981). Postadolescent paraphiliac sex offenders: Antiandrogenic and counseling therapy follow-up. Intemational Journal of Mental Health, 10, 122-133.
41.
Money, J., Wiedeking, C., Walker, P., Migeon, C., Meyer, W., & Borgaonkar, D. (1975). 47, XYY and 46, XY males with antisocial and/or sex-offending behavior: Antiandrogen therapy plus counseling . Psychoneuroendocrinology, 1, 165-178.
42.
Mugglestone, C.J. (1983). Drug treatment of hypersexuality. In D. Wheatley (Ed.), Psychapharmacology and sexual disorders (pp. 165-170). Oxford: Oxford University Press.
43.
Murray, M.A.F., Bancroft, J.H.H., Anderson, D.C., Tennent, T.G., & Carr, P.J. (1975). Endocrine changes in male sexual deviants after treatment with anti-androgens, oestrogens or tranquilizers. Journal of Endocrinology, 67, 179-188.
44.
Neumann, F., and Kalmus, J. (1991). Hormonal treatment of sexual deviations. Berlin: Diesbach Verlag.
45.
Neumann, F., Von Berswordt-Wallrabe, R., Elger, W., & Steinbeck, H. (1968). Activities of anti-androgens: Experiments in prepuberal and puberal animals in foetuses. In J. Tamm (Ed.), Testosterone (pp. 134-143). Proceedings of the Work Shop Conference, Tremsbuettel. Stuttgart: Georg Thieme Verlag.
46.
Ortmann, J. (1980). The treatment of sexual offenders. Castration and antihormone therapy. International Journal of Law and Psychiatry, 3, 443-451
47.
Pallone, N.J. (1990). Rehabilitating criminal sexual psychopaths. New Brunswick, NJ: Transaction.
48.
Perilstein, R.D., Upper, S., & Friedman, L.J. (1991). Three cases of paraphilias responsive to fluoxetine treatment. Journal of Clinical Psychiatry , 52, 169-170.
49.
Prentky, R.A. (1985). The neurochemistry and neuroendocrinology of sexual aggression: Review and metatheory. In D. P. Farrington & J. Gunn (Eds.), Aggression and dangerousness (Vol. 3, pp. 7-55). Sussex, England: John Wiley & Sons.
50.
Rada, R.T. (1981). Plasma androgens and the sex offender. Bulletin of the American Academy of Psychiatry and the Law, 8, 456-464.
51.
Rada, R.T., Laws, D.R., & Kellner, R. (1976). Plasma testosterone levels in the rapist. Psychosomatic Medicine, 38, 257-268.
52.
Rada, R.T., Laws, D.R., Kellner, R., Stivastava, L., & Peake, G. (1983). Plasma androgens in violent and nonviolent sex offenders. Bulletin of the American Academy of Psychiatry and the Law, 11, 149-158.
53.
Richer, M., & Crismon, M.L. (1993). Pharmacotherapy of sexual offenders. Annals of Pharmacotherapy, 27, 316-320.
Rousseau, L., Couture, M., Dupont, A., Labrie, F., & Couture, N. (1990). Effect of combined androgen blockade with an LHRH agonist and flutamide in one severe case of male exhibitionism. Canadian Journal of Psychiatry, 35, 338-341.
56.
Spodak, M.K., Falck, Z.A., & Rappeport, J.R. (1978). The hormonal treatment of paraphilias with depo-Provera. Criminal Justice and Behavior , 5, 304-314.
57.
Stein, D.J., Hollander, E., Anthony, D.T., Schneier, F.R., Fallon, M.D., Liebowitz, M.R., & Klein, D.F. (1992). Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias. Journal of clinical Psychiatry , 53, 267-271.
58.
Sterkmans, P., & Geerts, F. (1966). Is benperidol (RF 504) the specific drug for the treatment of successive and disinhibited sexual behavior? Acta Neurologica et Psychiatrica Belgica, 66, 1030-1040.
59.
Sturup, G.K. (1968). Treatment of sexual offenders in Herstedvester, Denmark: The rapists. Acta Psychiatrica Scandinavica, Suppl . 204, 44.
60.
Sun, M. (1984). Panel says depo-Provera not proved safe. Science, 226, 950-951.
61.
Symmers, W. St. C. (1968). Carcinoma of the breast in trans-sexual individuals after surgical and hormonal interference with primary and secondary sex characteristics . British Medical Journal, 2, 83-85.
62.
Tennent, T.G., Bancroft, J., & Cass, J. (1974). The control of deviant sexual behavior by drugs: A double-blind controlled study of benperidol, chlorpromazine and placebo . British Medical Joumal, 2, 261-271.
63.
Whittaker, L.H. (1959). Oestrogens and psychosexual disorders. Medical Journal of Australia, 2, 547-549.
64.
Whalen, R.E. (1984). Multiple actions of steroids and their antagonists . Archives of Sexual Behavior, 13, 497.
